Schizophrenia News and Research

Latest Schizophrenia News and Research

Factors linked to self-harm in schizophrenia identified

Polysubstance abuse and a high premorbid IQ are significantly associated with self-harm in patients with schizophrenia, UK researchers report.

11 Oct 2012

Antioxidant defense reduced in schizophrenia, bipolar disorder

Results from a Tunisian study suggest that the antioxidant defense system is altered in patients with schizophrenia and bipolar disorder.

11 Oct 2012

Inscopix to introduce nVista HD at Neuroscience 2012

Inscopix, Inc. will announce the launch of nVista HD, an end-to-end solution for in vivo brain imaging in freely behaving mice, this weekend at Neuroscience 2012 (SfN).

11 Oct 2012

Addiction and mental health burden higher than all cancers in Ontario

Mental illnesses and addictions take more of a toll on the health of Ontarians than cancer or infectious diseases, according to a new report by the Institute for Clinical Evaluative Sciences and Public Health Ontario - yet this burden could be reduced with treatment, say scientists from Canada's Centre for Addiction and Mental Health.

11 Oct 2012

Nicotine dependence linked to symptom severity in schizophrenia

Nicotine dependence is associated with increased symptom severity in patients with schizophrenia, UK study results show.

10 Oct 2012

Roitt's Essential Immunology receives BMA Book of the Year Award

John Wiley & Sons, Inc., today announced that Roitt's Essential Immunology, 12th Edition, has won the prestigious British Medical Association (BMA) Book of the Year Award.

10 Oct 2012

PUFA levels reduced in schizophrenia patients

Results from a systematic review and meta-analysis show that erythrocyte membrane concentrations of certain polyunsaturated fatty acids are reduced in the brains of people with schizophrenia.

9 Oct 2012

Kynurenic acid levels increased in bipolar patients with psychotic features

Bipolar disorder patients with a history of psychotic features have higher cerebrospinal fluid concentrations of kynurenic acid (KYNA) than those without such features, research shows.

9 Oct 2012

VTE risk highlighted for rheumatoid arthritis patients

Individuals with rheumatoid arthritis are at an increased risk for venous thromboembolism, research confirms.

8 Oct 2012

Fertility treatment may increase MS disease activity

Findings published in Annals of Neurology suggest that assisted reproduction technology treatment increases multiple sclerosis disease activity.

8 Oct 2012

Pesticide exposure may trigger food allergies

Results from the US National Health and Nutrition Examination Survey suggest that high exposure to dichlorophenols, chemicals found in pesticides and used for chlorinating water, may increase a person’s risk for developing food allergies.

5 Oct 2012

GRID1 thalamo-cortical gene variations absent in schizophrenia

Genetic variation in the glutamate receptor delta 1 gene affects gray matter of the anterior thalamus and left lateral prefrontal cortex in healthy individuals but not among patients with schizophrenia, suggest findings published in the Journal of Psychiatric Research.

5 Oct 2012

Social, metacognition deficits in schizophrenia predict dysfunction type

Research findings suggest that deficits in social cognition and metacognition among individuals with schizophrenia represent different forms of dysfunction and symptomatology.

4 Oct 2012

RNA clue to MS disease course

Researchers say that the RNA profiles of peripheral blood mononuclear cells can identify two distinct subsets of patients with multiple sclerosis.

4 Oct 2012

Heart attacks linked with mortality risk in people with schizophrenia

The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).

4 Oct 2012

Court approves Abbott settlement for wrongly marketing Depakote

The pharmaceutical company will pay $1.5 billion for marketing the drug for non-approved uses.

4 Oct 2012

New spontaneous genetic mutations play a significant role in schizophrenia

Columbia University Medical Center (CUMC) researchers have identified dozens of new spontaneous genetic mutations that play a significant role in the development of schizophrenia, adding to the growing list of genetic variants that can contribute to the disease.

4 Oct 2012

Roundup: Individual mandate back on Fla. ballot; More Mass. doctors embrace new payment methods; Ga. hospital tax fight rages on

In a bid to remake Florida's judiciary, Republicans are asking voters to oust three state Supreme Court justices and give the Legislature greater power over Supreme Court appointments. ... In Florida, the issue is not same-sex marriage but another politically divisive matter: President Obama's health care law. In a 2010 ruling, the Florida Supreme Court removed from the ballot a nonbinding amendment allowing Floridians to refuse to buy mandatory health insurance.

4 Oct 2012

Executive attention deficits identified in first-episode schizophrenia

Patients with first-episode schizophrenia have impairments in executive attention but not in alerting or orienting attention, suggest findings published in Bipolar Disorders.

3 Oct 2012

First Edition: October 3, 2012

Kaiser Health News staff writer Jordan Rau reports: "Medicare's new readmission penalties for hospitals just got a bit tougher. The Centers for Medicare & Medicaid Services has discovered errors in its initial calculations in August. As a result, 1,422 hospitals with comparatively high readmission rates will lose slightly more money than they were expecting, according to a Kaiser Health News analysis of the revised penalties. Fifty-five hospitals will lose less than were previously told."

3 Oct 2012